Listed

Champions Oncology, Inc.: Form 10-Q for the period ended Jan 31, 2017

Filed with the SEC on Mar 17, 2017 and accepted by EDGAR at Mar 17, 2017, 13:54 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2017-01-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development3 months2016-11-01 to 2017-01-31$998.0kus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2016-05-01 to 2017-01-31$3.2mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2016-11-01 to 2017-01-31−$1.4mus-gaap:OperatingIncomeLoss
Operating income9 months2016-05-01 to 2017-01-31−$4.4mus-gaap:OperatingIncomeLoss
Income tax3 months2016-11-01 to 2017-01-31$0us-gaap:IncomeTaxExpenseBenefit
Income tax9 months2016-05-01 to 2017-01-31$7.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2016-11-01 to 2017-01-31−$1.4mus-gaap:NetIncomeLoss
Net income9 months2016-05-01 to 2017-01-31−$4.5mus-gaap:NetIncomeLoss
Diluted EPS3 months2016-11-01 to 2017-01-31−$0.13us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS9 months2016-05-01 to 2017-01-31−$0.44us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow3 months2016-11-01 to 2017-01-31−$684.0kus-gaap:NetCashProvidedByUsedInOperatingActivities
Operating cash flow9 months2016-05-01 to 2017-01-31−$3.2mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2016-05-01 to 2017-01-31$181.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2017-01-31$3.5mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2017-01-31$6.1mus-gaap:AssetsCurrent
Total assetsAt period end2017-01-31$7.5mus-gaap:Assets
Current liabilitiesAt period end2017-01-31$5.3mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2017-01-31$5.5mus-gaap:Liabilities
Shareholders' equityAt period end2017-01-31$2.0mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001628280-17-002681. Last ingested by Listed: Nov 10, 2026, 03:33 ET. Listed shows no prices and gives no investment advice.